Return on Equity (ROE)
Updated 368h ago
Sector Performance
26th percentileMAA
6.7%
Sector Median
13.8%
Sector Avg
31.4%
Deep Analysis
Return on Equity (ROE) measures how much profit a company generates for each dollar of shareholders' equity—at 6.7%, MAA earns less than 7 cents per dollar of equity, well below the sector median of 14.4% and placing it in the 25th percentile of peers.
Both the year-over-year and quarter-over-quarter changes are unavailable, so no trend direction can be assessed from the single historical value of 6.7%. The combination of a low ROE with no trend data means the risk of below-average profitability persists without any visible improvement or deterioration. This persistent underperformance relative to peers suggests limited investment opportunity from a profitability standpoint. The metric contradicts a neutral verdict because a 25th-percentile ROE is clearly below average, yet the lack of trend data prevents a stronger negative call, leaving the overall stance as neutral.
Frequently Asked Questions
What does the Return on Equity (ROE) tell investors about MAA?
ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.
How is the Return on Equity (ROE) calculated?
Return on Equity (ROE) is calculated as: Net Income / Shareholders' Equity.
Who are MAA's closest peers by Return on Equity (ROE)?
The closest peers by Return on Equity (ROE) include: MRNA (-36.6%), FICO (-37.3%), XRAY (-37.7%), VRSN (-38.3%), MSCI (-45.3%).
The Formula
Net Income / Shareholders' Equity
Why It Matters
ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.
Master MAA's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full MAA research report →MAA
6.7%
Sector Median
13.8%
Sector Avg
31.4%
How MAA's Return on Equity (ROE) compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.